These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 22560821)
1. Coeliac disease in irritable bowel syndrome (Rome III) in Southeast Iran. Bakhshipour A; Nezam SK; Zakeri Z; Gharibi R; Bahari A; Kaykhaei MA Arab J Gastroenterol; 2012 Mar; 13(1):24-7. PubMed ID: 22560821 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of celiac disease in Iranian patients with irritable bowel syndrome: a cross-sectional study. Shayesteh AA; Hajiani E; Hashemi SJ; Masjedizadeh A; Latifi SM; Shayesteh M J Dig Dis; 2014 Jan; 15(1):12-7. PubMed ID: 24320042 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of celiac disease in patients with irritable bowel syndrome. El-Salhy M; Lomholt-Beck B; Gundersen D Mol Med Rep; 2011; 4(3):403-5. PubMed ID: 21468583 [TBL] [Abstract][Full Text] [Related]
4. The prevalence of coeliac disease in patients fulfilling Rome III criteria for irritable bowel syndrome. Shalaby SA; Sayed MM; Ibrahim WA; Abdelhakam SM; Rushdy M Arab J Gastroenterol; 2016 Jun; 17(2):73-7. PubMed ID: 27349575 [TBL] [Abstract][Full Text] [Related]
5. [Frequency of celiac disease and irritable bowel syndrome coexistance and its influence on the disease course]. Zwolińska-Wcisło M; Galicka-Latała D; Rozpondek P; Rudnicka-Sosin L; Mach T Przegl Lek; 2009; 66(3):126-9. PubMed ID: 19689036 [TBL] [Abstract][Full Text] [Related]
6. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. Akbari MR; Mohammadkhani A; Fakheri H; Javad Zahedi M; Shahbazkhani B; Nouraie M; Sotoudeh M; Shakeri R; Malekzadeh R Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1181-6. PubMed ID: 17033439 [TBL] [Abstract][Full Text] [Related]
7. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Locke GR; Murray JA; Zinsmeister AR; Melton LJ; Talley NJ Mayo Clin Proc; 2004 Apr; 79(4):476-82. PubMed ID: 15065612 [TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome: a 6-year prospective cohort study. Cristofori F; Fontana C; Magistà A; Capriati T; Indrio F; Castellaneta S; Cavallo L; Francavilla R JAMA Pediatr; 2014 Jun; 168(6):555-60. PubMed ID: 24756157 [TBL] [Abstract][Full Text] [Related]
9. Irritable bowel syndrome: a population based study. Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812 [TBL] [Abstract][Full Text] [Related]
10. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Ersryd A; Posserud I; Abrahamsson H; Simrén M Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480 [TBL] [Abstract][Full Text] [Related]
11. Undiagnosed Celiac Disease In Patients Presenting With Irritable Bowel Syndrome Symptoms. Khayyat YM J Ayub Med Coll Abbottabad; 2020; 32(1):18-23. PubMed ID: 32468748 [TBL] [Abstract][Full Text] [Related]
12. [Immunological profile of coeliac disease in a subgroup of patients with symptoms of irritable bowel syndrome]. Elloumi H; El Assoued Y; Ghédira I; Ben Abdelaziz A; Yacoobi MT; Ajmi S Tunis Med; 2008 Sep; 86(9):802-5. PubMed ID: 19472779 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case-control study. Sánchez-Vargas LA; Thomas-Dupont P; Torres-Aguilera M; Azamar-Jacome AA; Ramírez-Ceervanes KL; Aedo-Garcés MR; Meixueiro-Daza A; Roesch-Dietlen F; Grube-Pagola P; Vivanco-Cid H; Remes-Troche JM Neurogastroenterol Motil; 2016 Jul; 28(7):994-1000. PubMed ID: 26914655 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of celiac disease in Indian patients with irritable bowel syndrome and uninvestigated dyspepsia. Sharma H; Verma AK; Das P; Dattagupta S; Ahuja V; Makharia GK J Dig Dis; 2015 Aug; 16(8):443-8. PubMed ID: 25959064 [TBL] [Abstract][Full Text] [Related]
15. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study. Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652 [TBL] [Abstract][Full Text] [Related]
16. Celiac Disease in Patients Fulfilling the Rome III Criteria for Irritable Bowel Syndrome Attending Gastroenterology Department of A Tertiary Care Hospital in Bangladesh. Chowdhury MK; Chakraborty R; Gope S; Rahman MA; Miah AR; Raihan AS; Sarkar S; Paul BK; Ferdousi KR Mymensingh Med J; 2016 Jan; 25(1):102-8. PubMed ID: 26931258 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome. Korkut E; Bektas M; Oztas E; Kurt M; Cetinkaya H; Ozden A Eur J Intern Med; 2010 Oct; 21(5):389-92. PubMed ID: 20816591 [TBL] [Abstract][Full Text] [Related]
18. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Chang L; Lee OY; Naliboff B; Schmulson M; Mayer EA Am J Gastroenterol; 2001 Dec; 96(12):3341-7. PubMed ID: 11774947 [TBL] [Abstract][Full Text] [Related]
19. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece. Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207 [TBL] [Abstract][Full Text] [Related]
20. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation. Malagelada JR Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]